Showing results (311-320 of 408) with videos related to

Sort By:
Pageof 41
Nature|January 6, 2012
Vaccine protection against acquisition of neutralization-resistant SIV challenges in rhesus monkeysDan H Barouch, Jinyan Liu, Hualin Li, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|November 2, 2025
Hydrogel formulations for sustained-release of broadly neutralizing antibodiesCarolyn K Jons, Catherine M Kasse, Bryan T Mayer, et al.
Cell Reports|October 26, 2018
Completeness of HIV-1 Envelope Glycan Shield at Transmission Determines Neutralization BreadthKshitij Wagh, Edward F Kreider, Yingying Li, et al.
Journal of Virology|February 10, 2017
HIV/AIDS Vaccine Candidates Based on Replication-Competent Recombinant Poxvirus NYVAC-C-KC Expressing Trimeric gp140 and Gag-Derived Virus-Like Particles or Lacking the Viral Molecule B19 That Inhibits Type I Interferon Activate Relevant HIV-1-Specific B and T Cell Immune Functions in Nonhuman PrimatesJuan García-Arriaza, Beatriz Perdiguero, Jonathan L Heeney, et al.
Mabs|February 2, 2023
Bispecific antibody CAP256.J3LS targets V2-apex and CD4-binding sites with high breadth and potencyBaoshan Zhang, Jason Gorman, Young D Kwon, et al.
The Journal of Infectious Diseases|August 29, 2014
Induction of HIV-1-specific mucosal immune responses following intramuscular recombinant adenovirus serotype 26 HIV-1 vaccination of humansLindsey R Baden, Jinyan Liu, Hualin Li, et al.
Cell|February 1, 2020
Restriction of HIV-1 Escape by a Highly Broad and Potent Neutralizing AntibodyPhilipp Schommers, Henning Gruell, Morgan E Abernathy, et al.
Plos Pathogens|June 4, 2021
Structural and genetic convergence of HIV-1 neutralizing antibodies in vaccinated non-human primatesFangping Cai, Wei-Hung Chen, Weimin Wu, et al.
Plos Pathogens|March 19, 2013
A gp41 MPER-specific llama VHH requires a hydrophobic CDR3 for neutralization but not for antigen recognitionDavid Lutje Hulsik, Ying-ying Liu, Nika M Strokappe, et al.
Plos One|January 26, 2010
Analysis of memory B cell responses and isolation of novel monoclonal antibodies with neutralizing breadth from HIV-1-infected individualsDavide Corti, Johannes P M Langedijk, Andreas Hinz, et al.
Pageof 41